IMCD (OTCMKTS:IMCDY) Short Interest Update

IMCD (OTCMKTS:IMCDY) was the target of a significant growth in short interest in September. As of September 15th, there was short interest totaling 5,092 shares, a growth of 74.9% from the August 31st total of 2,912 shares. Based on an average daily volume of 15,758 shares, the short-interest ratio is presently 0.3 days.

Analysts Set New Price Targets

A number of brokerages recently commented on IMCDY. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of IMCD in a research report on Thursday, July 30th. UBS Group upgraded IMCD to a “buy” rating in a report on Tuesday, July 14th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $72.50.

IMCD Trading Down 1.6%

OTCMKTS:IMCDY opened at $53.59 on Friday. The company’s 50-day moving average is $55.46 and its two-hundred day moving average is $52.68. IMCD has a 1-year low of $39.76 and a 1-year high of $61.56.

IMCD Company Profile

IMCD N.V. is a global distributor and formulator of specialty chemicals and food ingredients. The company connects manufacturers of chemical products and ingredients with customers across a range of industries, providing sourcing, technical support, formulation assistance and supply-chain services.

Its products serve markets including coatings and construction, advanced materials, lubricants and fuels, personal care, pharmaceuticals, food and nutrition, and home care. IMCD also operates application laboratories and technical centers that help customers develop and adapt formulations for specific applications and regulatory requirements.

Founded in Rotterdam in 1995, IMCD has expanded through organic growth and acquisitions into a global business serving customers and suppliers across Europe, the Middle East and Africa, the Americas, and the Asia-Pacific region.